Release of Cervical Muscle Tension Improves Psychological Stress and Symptoms of Moderate-to-Severe Atopic Dermatitis: a Case Series with 20 Patients.
Atopic dermatitis
Cervical muscular tension
Itch–scratch cycle
Psychological stress
Journal
Dermatology and therapy
ISSN: 2193-8210
Titre abrégé: Dermatol Ther (Heidelb)
Pays: Switzerland
ID NLM: 101590450
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
21
07
2022
accepted:
08
09
2022
pubmed:
22
9
2022
medline:
22
9
2022
entrez:
21
9
2022
Statut:
ppublish
Résumé
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease that is triggered by intense pruritus, impaired skin barrier function, and immune responses to allergenic substances. Break-through therapies for AD include molecular-targeted drugs and the effective management of severe symptoms of AD. However, patients with clinical improvements may continue scratching owing to the influence of psychological stress, which might lead to quick relapses of stressors and subsequent intensive scratching. New drugs may be ineffective because of such scratching behavior caused by stressors. Therefore, it may be useful to consider adjunctive treatment options that focus on external stressors as triggers of deterioration of AD. We hypothesized that improvement of psychological stress by relieving cervical muscle tension would reduce pruritus and atopic symptoms. Overall, 21 patients with moderate-to-severe AD were treated to relieve cervical muscular tension using Spineliner SA201, which assists in osteopathic manipulative treatment. We assessed the subjective and objective symptoms of AD, cervical muscle tension, which was evaluated using cervical range of motion (ROM), and psychological burden. Only moisturizers were applied topically during the study period, and no topical corticosteroid therapy was used. Twenty patients who completed the treatment demonstrated improvement in the symptoms of AD: changes on the visual analog scale (VAS) for pruritus were -44.2%, Eczema Area and Severity Index (EASI) was -67.9%, thymus and activation-regulated chemokine (TARC) was -56.2%, Hospital Anxiety and Depression Scale (HADS) was -27.2%, sleep disturbance was -49.7%, and Dermatology Life Quality Index (DLQI) was -46.7%. Additionally, the cervical muscle tension improved significantly: changes in cervical ROM were 14.7%. Release of cervical muscle tension may improve psychological stress and have an effect on moderate-to-severe AD. Atopic dermatitis is a chronic relapsing inflammatory skin disease triggered by intense pruritus, impaired skin barrier function, and immune responses. Standard dermatological therapies for patients with atopic dermatitis include topical glucocorticoid treatments. In some cases, scratching and inflammation could not be adequately controlled, a relapse could not be prevented after remission, and their efficacy is limited. Break-through therapies for atopic dermatitis include new molecular biological drugs, which have demonstrated significantly improved and effective management of severe atopic symptoms. However, patients with clinical improvements may continue scratching owing to psychological stress, which might lead to quick relapses of stressors and subsequent intensive scratching. New drugs may be ineffective owing to such scratching behavior caused by stressors. Therefore, it may be useful to consider adjunctive treatment options focusing on external stressors as triggers for worsening atopic dermatitis. We hypothesized that improvement of psychological stress by relieving cervical muscle tension would reduce pruritus and atopic symptoms. Overall, 21 patients with moderate-to-severe atopic dermatitis were treated to relieve cervical muscular tension using Spineliner SA201, which assists in osteopathic manipulative treatment. We assessed the subjective and objective atopic symptoms, cervical muscle tension, and psychological burden. Only moisturizers were applied topically during the study period, and no topical corticosteroid therapy was used. Twenty patients completed the treatment, atopic symptoms improved significantly, cervical muscular tension improved, and the psychological burden decreased with the treatment. Release of cervical muscle tension may improve psychological stress and affect moderate-to-severe atopic dermatitis.
Autres résumés
Type: plain-language-summary
(eng)
Atopic dermatitis is a chronic relapsing inflammatory skin disease triggered by intense pruritus, impaired skin barrier function, and immune responses. Standard dermatological therapies for patients with atopic dermatitis include topical glucocorticoid treatments. In some cases, scratching and inflammation could not be adequately controlled, a relapse could not be prevented after remission, and their efficacy is limited. Break-through therapies for atopic dermatitis include new molecular biological drugs, which have demonstrated significantly improved and effective management of severe atopic symptoms. However, patients with clinical improvements may continue scratching owing to psychological stress, which might lead to quick relapses of stressors and subsequent intensive scratching. New drugs may be ineffective owing to such scratching behavior caused by stressors. Therefore, it may be useful to consider adjunctive treatment options focusing on external stressors as triggers for worsening atopic dermatitis. We hypothesized that improvement of psychological stress by relieving cervical muscle tension would reduce pruritus and atopic symptoms. Overall, 21 patients with moderate-to-severe atopic dermatitis were treated to relieve cervical muscular tension using Spineliner SA201, which assists in osteopathic manipulative treatment. We assessed the subjective and objective atopic symptoms, cervical muscle tension, and psychological burden. Only moisturizers were applied topically during the study period, and no topical corticosteroid therapy was used. Twenty patients completed the treatment, atopic symptoms improved significantly, cervical muscular tension improved, and the psychological burden decreased with the treatment. Release of cervical muscle tension may improve psychological stress and affect moderate-to-severe atopic dermatitis.
Identifiants
pubmed: 36129669
doi: 10.1007/s13555-022-00814-x
pii: 10.1007/s13555-022-00814-x
pmc: PMC9515250
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2383-2395Informations de copyright
© 2022. The Author(s).
Références
Int Arch Allergy Immunol. 2007;144(1):1-9
pubmed: 17449959
J Allergy Clin Immunol. 2003 Mar;111(3):598-602
pubmed: 12642843
Clin Cosmet Investig Dermatol. 2021 Aug 03;14:959-969
pubmed: 34377004
Evid Based Complement Alternat Med. 2019 May 2;2019:1907578
pubmed: 31186656
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60
pubmed: 26226355
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
N Engl J Med. 2016 Dec 15;375(24):2335-2348
pubmed: 27690741
Br J Dermatol. 2010 Mar;162(3):587-93
pubmed: 19995367
Allergy. 2012 Jan;67(1):99-106
pubmed: 21951293
JAMA Dermatol. 2021 Sep 01;157(9):1047-1055
pubmed: 34347860
Acta Derm Venereol. 2016 Feb;96(2):157-61
pubmed: 26073701
Acta Derm Venereol. 2015 Nov;95(8):943-7
pubmed: 25916555
Acta Derm Venereol. 2010 Nov;90(6):582-8
pubmed: 21057740
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Br J Dermatol. 2019 Apr;180(4):689-690
pubmed: 30933337
Int J Behav Med. 1994;1(4):354-70
pubmed: 16250795
Br J Dermatol. 1999 Oct;141(4):698-702
pubmed: 10583119
J Bodyw Mov Ther. 2013 Jan;17(1):89-94
pubmed: 23294689
Int J Dermatol. 2021 Feb;60(2):190-195
pubmed: 32989751
Int J Legal Med. 2004 Aug;118(4):235-9
pubmed: 15197558
J Epidemiol Community Health. 1999 Jan;53(1):46-50
pubmed: 10326053
J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e239-42
pubmed: 22621673
Dermatol Clin. 2017 Jul;35(3):291-297
pubmed: 28577798
Exp Dermatol. 2001 Feb;10(1):11-8
pubmed: 11168575
Immunol Rev. 2017 Jul;278(1):246-262
pubmed: 28658541
Acta Derm Venereol. 2012 Jan;92(1):57-61
pubmed: 21879233
JAAD Case Rep. 2020 Apr 24;6(6):510-513
pubmed: 32490112
J Am Acad Dermatol. 2016 Feb;74(2):288-94
pubmed: 26685719
J Allergy Clin Immunol. 2001 Mar;107(3):535-41
pubmed: 11240957
Br J Dermatol. 2005 Jun;152(6):1161-4
pubmed: 15948976
Exp Dermatol. 2020 Aug;29(8):699-702
pubmed: 32614478
J Clin Med. 2021 Mar 21;10(6):
pubmed: 33801061
Arch Dermatol Res. 2012 May;304(4):305-12
pubmed: 22146836
Dermatol Pract Concept. 2021 Sep 01;11(4):e2021091
pubmed: 34631261
Neurosci Biobehav Rev. 2018 Apr;87:17-26
pubmed: 29374516
Acta Derm Venereol. 2012 Sep;92(5):497-501
pubmed: 22102095
J Clin Lab Anal. 2020 Jun;34(6):e23214
pubmed: 32068307
Aging Cell. 2015 Aug;14(4):625-34
pubmed: 25902870
Dermatology. 2015;230(1):27-33
pubmed: 25613671